Sunshine Biopharma (SBFM) Other Non Operating Income (2015 - 2026)
Sunshine Biopharma's (SBFM) quarterly Other Non Operating Income came in at -$6.0 in Q2 2026, down 100.31% on a YoY basis from $1940.0 in Q2 2025, and up 66.67% quarter-over-quarter from -$18.0 in Q1 2026.
Powered by 
Analysis
Sunshine Biopharma (SBFM) Other Non Operating Income (2015 - 2026) Analysis & Trends
Sunshine Biopharma (SBFM) has reported Other Non Operating Income for 12 consecutive years, with -$6.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Other Non Operating Income fell 100.31% year-over-year to -$6.0; the trailing twelve-month figure through Jun 2026 stood at $52572.0 (up 123.65% YoY), and the FY2025 full-year result was $54987.0, down 1.97% from the prior year.
- Other Non Operating Income climbed to -$6.0 in Q2 2026 per SBFM's latest filing, from -$18.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $286535.0 in Q2 2024 and bottomed at -$239829.0 in Q4 2024.
- Historically, Other Non Operating Income has averaged $7157.5 across 5 years, with a median of $25.0 in 2022.
- The widest YoY moves for Other Non Operating Income: up 109883.52% in 2024, down 614846.15% in 2024.
- Over 5 years, Other Non Operating Income stood at $25.0 in 2022, then slumped by 256.0% to -$39.0 in 2023, then sank by 614846.15% to -$239829.0 in 2024, then soared by 121.83% to $52343.0 in 2025, then plunged by 100.01% to -$6.0 in 2026.
- According to Business Quant data, Other Non Operating Income over the past three periods registered -$6.0, -$18.0, and $52343.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.61 Bn | 38.95 Bn | 2.15 Bn |
| 2 | Viatris | 19.18 Bn | 18.30 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.85 Bn | 9.68 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.36 Bn | 518.87 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 994.21 Mn | 704.09 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 405.56 Mn | 364.31 Mn | 17.15 Mn |
| 10 | Sunshine Biopharma | 1.56 Mn | -12.19 Mn | 2.43 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6.00 |
| Mar 31, 2026 | -18.00 |
| Dec 31, 2025 | 52,343.00 |
| Sep 30, 2025 | 253.00 |
| Jun 30, 2025 | 1,940.00 |
| Mar 31, 2025 | 451.00 |
| Dec 31, 2024 | -239,829.00 |
| Sep 30, 2024 | 15,153.00 |
| Jun 30, 2024 | 286,535.00 |
| Mar 31, 2024 | -5,767.00 |
| Dec 31, 2023 | -39.00 |
| Sep 30, 2023 | 40.00 |
| Jun 30, 2023 | -261.00 |
| Mar 31, 2023 | 15.00 |
| Sep 30, 2022 | 25.00 |
| Jun 30, 2022 | 10,852.00 |
| Mar 31, 2022 | -9.00 |
| Dec 31, 2021 | -58,890.00 |
| Sep 30, 2021 | 7,688.00 |
| Jun 30, 2021 | 221.00 |